{"name":"Parabilis Medicines, Inc.","slug":"parabilis-medicines-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNLTF4VjdIamFPMjZRem02ckQtMTUtbm5kTHNRanRpNG9oNXlENlZocmJrXzFveWFyTV9TTzZZQ3EtLXRBekFFckVfQ0tOR3Q4N2lQWDVISm9yMjMxbGNUa1pIMk9Ga0NCUGhNYk1NOUVleENYX0JXcWZPek9jbkdtbTAtdGtGYWZXYlFyN2xGQUhWZw?oc=5","date":"2026-02-06","type":"pipeline","source":"BioWorld News","summary":"2026 kicks off with $10.8B January financing haul - BioWorld News","headline":"2026 kicks off with $10.8B January financing haul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZEcyb2tWYTVwQU9YTUxmTTVCci1GQWpmUXJ5Wl9UR1NlbGx5bVNVY2ZPV3R2WUU3aXJKQ0RDc1V3YmtGT3U0dFE5a1NOeVo5QkthWV9DMWVPckNyeXM2aGVSNkcxYTBYbVJaSWZ1NHZyZmtkX2dfamctMnM2MmprdXhGQWVMUkxHVkc0X0lPZnpobjZzYlNRXw?oc=5","date":"2026-01-09","type":"pipeline","source":"The Pharma Letter","summary":"Parabilis Medicines closes $305 million financing - The Pharma Letter","headline":"Parabilis Medicines closes $305 million financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOeGxEZG4tRUE5c054N0JtcXlGYnJLUlZtWmJQbWRPZF80em95RXJJZXA2OTJCRV9iUk9CMTNzTnU4Wm5mTV80eGNFRTZ1VHFDNFNhVHo1MDVRbzlZS3RhRTZsdW55eUxaRlczTUxhZFVUUlU4N19DQ0JUcmJhZHVQbFdB?oc=5","date":"2026-01-09","type":"pipeline","source":"pharmaphorum","summary":"Parabilis scores $305m in bumper biofinancing week - pharmaphorum","headline":"Parabilis scores $305m in bumper biofinancing week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNZHVLOE9qb1dGTUhmSlhIRm5kVWMtQlpGaGdFS0w1MTZqWDJXNDNaYTZYNnFabU1EZG5YV3BLeWV1OVdhbzVxb2ZXNVlYQ25UNFdPcWhfR2F3MFFXZGZSelVuYTRUdFo5cW8wZTdWSURSdXJ1d2hVQUxjaGk3R05zNnh4M0ZITW5HYVVkbw?oc=5","date":"2026-01-08","type":"pipeline","source":"statnews.com","summary":"Parabilis Medicines raises $305 million as CEO warms to an IPO - statnews.com","headline":"Parabilis Medicines raises $305 million as CEO warms to an IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRElDcXo3VjNjRlNRTTVrTkpLZm11WWpQcGxoOFpiREo4V0JmZk5lS18xU080OGVXcWhOajhGLWhSMHItTkw4WmZjNFB5WkZ5d0tRZkxRTFktTVhVVTRCTlE4OWM3LVFJcDZ2cHVrbnZkak1PbjRkMHhlVlAtcHVaSVNEVzJaeTlZeC1uUWh3eUR6cy0xelEtVnRsN0h2YkNvNXZxOTFR?oc=5","date":"2026-01-08","type":"pipeline","source":"Fierce Biotech","summary":"Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug - Fierce Biotech","headline":"Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPYnZqX1kzUmdxUGxFcHAwbldvd2s0Y0RqRmpkcXlWUkZvdzlTNUZldmlnUmw3czl2ZmEwNTRaVnRfRnY5Qlo1NXhrcE93bWpTR2hnMHlXaTdjZExheWVOYmlGclNLNXJFSE1NNUE1S3I0a2NTdzBYOVlaVU1yWnNuZ2lZVHl1aW1LckFORG9DVzBxQmJQSmMxemNVZlB2dy1HQ1E?oc=5","date":"2026-01-08","type":"pipeline","source":"BioPharma Dive","summary":"Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz - BioPharma Dive","headline":"Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOYlNCTVRjMlZBbzRNRk9uX0xLbERvMUFJUUlwb1VKYnJlWk1yM2toSU9fZ0JnM1lOTGhQM0hZdFZvenJJUzFFTks4cUR5dlZhYnFKMkhyOHVwX3I5emRQRUE4dUhaZThxbjdwZ21iMHNDYU05bm11eHgtWERPLUZfdFZfVmNvd2NLT3o5czhaVm9RSU1jVHV1Zi1aM3cwc0dmQ3AzWkJ6WDlaVjVjaEE?oc=5","date":"2026-01-08","type":"pipeline","source":"BioSpace","summary":"Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug - BioSpace","headline":"Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQd1c4OFA0Ml9lYmJ3Zi1tdU1Gd3FpMUwtRFoyc0dsMk1aRmFLUzlVTzN0WXMyanZvblp2Q0dyNEJEVzBrSHNXYkRiaklSS3J5SlVSd1FRdWZTMUVtbGROTGVWTEFrSERwVTVNaFh3MU00WDVNR3hLRUZIY3B0NmR3WTZnQXYwRTdNQkNwTHhRSVNCaFVTVmx5VGRuTER1X2kwNlVBYTlrOHA4QXBJN1E?oc=5","date":"2025-09-03","type":"pipeline","source":"Contract Pharma","summary":"Parabilis Medicines Names Fawzi Benzaghou Chief Medical Officer - Contract Pharma","headline":"Parabilis Medicines Names Fawzi Benzaghou Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNblRLdVBNNWhyQnp2THE5TTMtUWRGQWU4cE5faml5eXR5SmpsdVNWdEJac2xPdDVGVTNvNGd3aFBCOWloV3JCZlVmeEtUcEM1b2lVdlVSMmw5VEU4NFEwcWM0emJONjhrRU5fYW1qQTBKWGppNWZVdFVoUjF4aEhwVi04aFBvNGJDOFdHeDJ6LU91a01QcmdfSTJPLUozYTU2?oc=5","date":"2025-06-24","type":"pipeline","source":"Pharma Voice","summary":"How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’ - Pharma Voice","headline":"How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQT0xyelZ4TWowUUpEM29Pdng4YnVBVWdsRUhYZ3NuQ1FETS1ZVjhlWEdqNGExMDZLWE5uOFVFSVN4Ym9qMEN3SFBkUmFCbWdfdDZBdWR4enpvdmVmRVUwZW1TRXI5YWVwdnlOT1l5VjFZM1VXRzBiMkVQN0VHWmYydXZyRkZUOVF5cW9XWlQ3TnpFVzBJR09NS3JWOWsyZDNLM05mbHRYX1M0eXlZ?oc=5","date":"2024-10-28","type":"pipeline","source":"Fierce Pharma","summary":"Fog clears to reveal Parabilis, a rebranded cancer biotech with big name backers - Fierce Pharma","headline":"Fog clears to reveal Parabilis, a rebranded cancer biotech with big name backers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOM3JJWHh2cjFSR0pEcFdtZmRicjgyMVNXaUZReWtyQTFCcF9uNjQtckJSVWwxVEpnaURIbzFtMkZCVU56RDJYRnNrTFVHZ3U5NUJDMU1IemRXTnhpckY4T3ZQNUREY2F2MktXcFM5R2xNN1dmaUJaOEJsdk1KZmRZTDd1N25lZm5uNDJXSVBjSnpHM0pNWVd3OTFRNDRBbWRZVk8zd0s5UktDcE4xdlFRRnl5TTJSWDRsNXBWakFNYkVfVkdMbjVmWGlWdXYzenRKUHRITmlTYndHNDVTMzhtaWZ6UEM4NmVUZDRPbmd3?oc=5","date":"2024-10-28","type":"pipeline","source":"BioSpace","summary":"Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform - BioSpace","headline":"Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platf","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQYjJlQURDbTY0NnJMa2ZkV01yNXlTRW9HSWVEZFd5c2hHbHVHdV9KSmVnY2MyN0hBNjhqVzgtZEV4LWhaZzBkU2lPbFJ0cVpCQl9QSnVNeXhDeF81UlR3YTVjYWYyMlpNWEIwaHBtRUx3ZzJma2xVT2xwX25vZFVoX2ZONnRVMlpxTDBmSldPT1djY2ZadUdhcFczbXZkcko3S2htWWY1c1k4NEhBSTNZRkV3enFneHZpajB6VkFDYmsxQmpoNlA3TjRFSzlReC15bGRRTG5RMC1xMkRJbS1JUWZ2RXd1eHVZWkExb0h0bEZvNkF2SU1oWnZvSXBEd01KTHE4OG9mMG5CWmd3ZW82RVlyb3Z1b196eV9va2RB?oc=5","date":"2024-03-01","type":"pipeline","source":"Business Wire","summary":"FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio - Business Wire","headline":"FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Pep","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}